Horizon Extends CRISPR License with ERS Genomics and Inks Partnership with Solentim – Genetic Engineering & Biotechnology News
Proactive Investors UK |
Horizon Extends CRISPR License with ERS Genomics and Inks Partnership with Solentim
Genetic Engineering & Biotechnology News Horizon Discovery extended its existing CRISPR licence with ERS Genomics, to give Horizon rights to use CRISPR-edited cell lines for the GMP manufacture of biotherapeutics. The Cambridge, U.K.-based company in parallel reported a two-year … CRISPR licence extension keeps Horizon Discovery at “forefront of gene editing” Horizon broadens gene editing capabilities: CRISPR license extension & grant-funded research |
